Submission NameMenSC Labs
University NameNational University of Singapore
Submission DescriptionMenSC Labs provides an end-to-end solution for harnessing menstrual blood as a stem cell source. Our proprietary collection and preservation system allows women to safely collect and transfer menstrual blood from home. Using our AI/ML model, we then analyze its viability for clinical applications.
Our platform makes stem cell therapy more accessible by using menstrual blood—a free, abundant, and non-invasive source. Traditional therapies cost ~$20,000 due to invasive harvesting. Our approach cuts costs significantly, making regenerative medicine affordable and accessible to more people.
We’ll collaborate with healthcare and commercial partners on joint ventures to develop clinical and non-clinical technologies, transitioning to long-term licensing. Commercial applications will use royalty-based licenses, while clinical partners will pay onboarding and annual maintenance fees.
UN Sustainable Development Goalsindustry, innovation, and infrastructure, reduced inequalities, good health and well-being, gender equality